Katie Kosko

Urban Health Today

Hispanic men have a low rate of guideline-appropriate prostate-specific antigen (PSA) screening, particularly if they are Black or Cuban, according to a study presented during the 25th Annual Meeting of the Society of Urologic Oncology.Between 2014 and 2017, Hispanic men aged 40 or older were recruited from four metropolitan areas across the United States: Bronx, New York; Chicago, Illinois; Miami, Florida; and San Diego, California. The prospective, population-based multicenter observational study, Hispanic Community Health Study/Study of Latinos, evaluated self-reported PSA testing of 3,484 Hispanic men.&ldquo;Hispanic men are significantly more likely to present with more advanced prostate cancer than non-Hispanic White [men],&rdquo; the researchers said. &ldquo;Unequal access to early prostate cancer detection may result in higher rates of prostate cancer diagnoses at an advanced stage.&rdquo;Study results showed that Black Hispanic men have the lowest odds of PSA screening in the population. Moreover, Cuban men aged 55-69 years had the lowest screening rates. Low PSA screening rates were also linked to poor primary care access. Specifically, for men aged 55-69 years with a lower BMI, low social support, or no personal doctor, remote check-up availability predicted lack of PSA screening.Older age increased the odds of PSA screening with more than half (56%) of those 70 years or older having been screened, followed by 46% for those aged 55-69 and 20% for those aged 40-54 years. Screening rates were higher among Hispanic men who were employed, had increased family cohesion, and more social support.&ldquo;These findings underscore the within-population screening heterogeneity in this diverse community and highlight areas of targeted intervention in community health screenings,&rdquo; the researchers said.<h4>Reference</h4>Manoharan A, Esquives BN, Penedo F, et al. Factors associated with prostate cancer screening among hispanic men: results from hispanic community health study/study of latinos (HCHS/SOL). Poster #26. Presented at the 25th Annual Meeting of the Society of Urologic Oncology; December 4-6, 2024; Dallas, Texas.

Lou Portero

Novel Mobile App Shows Promise for Managing Sickle Cell Disease Pain and Stress

Sickle Cell Disease

Tamara Thomas

Global Surge in Vaginal Cancer Highlights Need for HPV Vaccination

Gynecologic Cancer

Heather Knox

The Way Forward: Future of Blood Cancer Research Relies on Diversity

Blood Cancers

Latest News

PSA Screening Rates Are Low Among Hispanic Men

SUO 2024

Hispanic men who are Black or Cuban had the lowest rates of prostate-specific antigen screening.

About Us

Editorial Policy

Contributors & Partners

Contact Us

eNewsletters

Work With Us

Advertising

Career Center

GU Oncology Now

Blood Cancers Today

Cancer Nursing Today

DocWire News

MashupMD

Food Allergy Roundtable Discussions

Allergy

— Multiple Myeloma

Breast Cancer

Colorectal Cancer

Pancreatic Cancer

Prostate Cancer

Cancer

Diabetes

Gastroenterology

Heart Failure

Heart Disease Prevention

Heart Health

— Alzheimer’s Disease

Neurology

Public Health

Autoimmune Disease

Infectious Diseases

Obesity

Pediatrics

Digital Health

Dermatology

Pulmonology

Video Insights

Workforce News

More

Heart Disease in Women

Menopause

Reproductive Health

Women’s Neurology

Well Woman Today

Roundtables

Podcasts

Conferences

Viewpoints

Subscribe